Comparison of the HyperQ Versus Conventional Electrocardiogram (ECG) to Detect Ischemia
NCT ID: NCT00917800
Last Updated: 2013-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2009-05-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG
NCT00310622
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
NCT01325467
Stress Echocardiography Versus Exercise ECG (ExECG) in Women With Chest Pain
NCT02346565
HeartTrends HRV Algorithm for the Detection of Myocardial Ischemia
NCT02201017
HeartTrends Heart Rate Variability (HRV) Algorithm for the Diagnosis of Myocardial Ischemia
NCT01657006
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
suspected coronary artery disease
patients referred to angiography because of suspected coronary artery disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A patient who is able (i.e., no contraindications) to perform an exercise stress test
* A patient who signed an informed consent form.
Exclusion Criteria
* Wolff-Parkinson-White (pre-excitation) syndrome.
* Left Bundle branch block, Complete Right bundle branch block or QRS duration \> 120 ms, change in QRS morphology during exercise.
* Atrial Fibrillation or significant ventricular arrhythmia
* Treatment with Digoxin.
* Pacemaker.
* Having taken beta blockers within 24 hours before the exercise test.
* Pregnancy or suspected pregnancy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West German Heart Center Essen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
N. Reinsch
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raimund Erbel, MD
Role: PRINCIPAL_INVESTIGATOR
Director, West German Heart Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West German Heart Center
Essen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Essen 09-3981
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.